Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats

Por Pravetoni, Marco, Vervacke, Jeffrey S., Distefano, Mark D., Tucker, Ashli M., Laudenbach, Megan, Pentel, Paul R.
Publicado em 2014

The frequency of naïve and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse

Por Laudenbach, Megan, Baruffaldi, Federico, Vervacke, Jeffrey S, Distefano, Mark D, Titcombe, Philip J, Mueller, Daniel L, Tubo, Noah J, Griffith, Thomas S, Pravetoni, Marco
Publicado no J Immunol (2015)